Scholars@Duke

• Research
• 

  Selected Grants

  • CCL3 as a Developmental Therapeutic to Enhance Brain Tumor Therapy awarded by National Institutes of Health 2016 - 2021
  • EGFRvIII-targeted Bispecific T cell Engagers for brain tumors awarded by National Institutes of Health 2013 - 2019
  • Brain tumors with regulatory T-cells treated with EGFRvIII-specific T-cells awarded by National Institutes of Health 2013 - 2018
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Swartz, AM, Reap, E, Norberg, P, Schmittling, R, Janetzki, S, Sanchez-Perez, L, and Sampson, JH. "A simple and enzyme-free method for processing infiltrating lymphocytes from small mouse tumors for ELISpot analysis." Journal of Immunological Methods 459 (August 2018): 90-93.  Full Text
    • Swartz, AM, Batich, KA, Fecci, PE, and Sampson, JH. "Peptide vaccines for the treatment of glioblastoma." Journal of neuro-oncology 123, no. 3 (July 2015): 433-440. (Review)  Full Text
    • Batich, KA, Swartz, AM, and Sampson, JH. "Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma." Expert Opinion on Biological Therapy 15, no. 1 (January 2015): 79-94. (Review)  Full Text
    • Swartz, AM, Li, Q-J, and Sampson, JH. "Rindopepimut: a promising immunotherapeutic for the treatment of glioblastoma multiforme." Immunotherapy 6, no. 6 (January 2014): 679-690. (Review)  Full Text
    • McNutt, P, Hamilton, T, Nelson, M, Adkins, A, Swartz, A, Lawrence, R, and Milhorn, D. "Pathogenesis of acute and delayed corneal lesions after ocular exposure to sulfur mustard vapor." Cornea 31, no. 3 (March 2012): 280-290.  Full Text
    • McNutt, P, Lyman, M, Swartz, A, Tuznik, K, Kniffin, D, Whitten, K, Milhorn, D, and Hamilton, T. "Architectural and biochemical expressions of mustard gas keratopathy: preclinical indicators and pathogenic mechanisms." Plos One 7, no. 8 (January 2012): e42837-null.  Full Text

  • Book Sections

    • Batich, KA, Swartz, AM, and Sampson, JH. "Preconditioning Vaccine Sites for mRNA-Transfected Dendritic Cell Therapy and Antitumor Efficacy." 819-838. January 2016.  Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.